UFP TECHNOLOGIES INC (UFPT) Stock Fundamental Analysis
NASDAQ:UFPT - Nasdaq - US9026731029 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to UFPT. UFPT was compared to 188 industry peers in the Health Care Equipment & Supplies industry. UFPT scores excellent on profitability, but there are some minor concerns on its financial health. UFPT is growing strongly while it is still valued neutral. This is a good combination! These ratings could make UFPT a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
UFPT had positive earnings in the past year.
In the past year UFPT had a positive cash flow from operations.
UFPT had positive earnings in each of the past 5 years.
UFPT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 9.88%, UFPT belongs to the best of the industry, outperforming 93.09% of the companies in the same industry.
UFPT has a better Return On Equity (17.60%) than 92.02% of its industry peers.
With an excellent Return On Invested Capital value of 13.23%, UFPT belongs to the best of the industry, outperforming 95.21% of the companies in the same industry.
UFPT had an Average Return On Invested Capital over the past 3 years of 11.64%. This is above the industry average of 7.89%.
The 3 year average ROIC (11.64%) for UFPT is below the current ROIC(13.23%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.88% | ||
| ROE | 17.6% | ||
| ROIC | 13.23% |
ROA(3y)10.52%
ROA(5y)8.58%
ROE(3y)16.84%
ROE(5y)13.25%
ROIC(3y)11.64%
ROIC(5y)9.67%
1.3 Margins
Looking at the Profit Margin, with a value of 11.59%, UFPT belongs to the top of the industry, outperforming 88.30% of the companies in the same industry.
UFPT's Profit Margin has improved in the last couple of years.
UFPT has a Operating Margin of 16.57%. This is amongst the best in the industry. UFPT outperforms 87.77% of its industry peers.
UFPT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 28.99%, UFPT is doing worse than 76.06% of the companies in the same industry.
UFPT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.57% | ||
| PM (TTM) | 11.59% | ||
| GM | 28.99% |
OM growth 3Y16.51%
OM growth 5Y5.87%
PM growth 3Y14.91%
PM growth 5Y3.22%
GM growth 3Y5.49%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UFPT is creating some value.
The number of shares outstanding for UFPT has been increased compared to 1 year ago.
The number of shares outstanding for UFPT has been increased compared to 5 years ago.
The debt/assets ratio for UFPT is higher compared to a year ago.
2.2 Solvency
UFPT has an Altman-Z score of 6.15. This indicates that UFPT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.15, UFPT belongs to the best of the industry, outperforming 82.45% of the companies in the same industry.
UFPT has a debt to FCF ratio of 3.10. This is a good value and a sign of high solvency as UFPT would need 3.10 years to pay back of all of its debts.
UFPT has a better Debt to FCF ratio (3.10) than 88.30% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that UFPT is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.47, UFPT perfoms like the industry average, outperforming 42.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 3.1 | ||
| Altman-Z | 6.15 |
ROIC/WACC1.49
WACC8.86%
2.3 Liquidity
A Current Ratio of 2.58 indicates that UFPT has no problem at all paying its short term obligations.
With a Current ratio value of 2.58, UFPT perfoms like the industry average, outperforming 49.47% of the companies in the same industry.
UFPT has a Quick Ratio of 1.45. This is a normal value and indicates that UFPT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of UFPT (1.45) is worse than 60.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.45 |
3. Growth
3.1 Past
UFPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.35%, which is quite impressive.
Measured over the past years, UFPT shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.55% on average per year.
UFPT shows a strong growth in Revenue. In the last year, the Revenue has grown by 34.43%.
The Revenue has been growing by 20.52% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)31.35%
EPS 3Y53.29%
EPS 5Y23.55%
EPS Q2Q%34.76%
Revenue 1Y (TTM)34.43%
Revenue growth 3Y34.72%
Revenue growth 5Y20.52%
Sales Q2Q%41.08%
3.2 Future
UFPT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.28% yearly.
Based on estimates for the next years, UFPT will show a quite strong growth in Revenue. The Revenue will grow by 9.93% on average per year.
EPS Next Y14.03%
EPS Next 2Y13.82%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue Next Year20.35%
Revenue Next 2Y12.73%
Revenue Next 3Y9.93%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
UFPT is valuated quite expensively with a Price/Earnings ratio of 28.52.
Based on the Price/Earnings ratio, UFPT is valued a bit cheaper than 75.00% of the companies in the same industry.
UFPT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 23.66 indicates a rather expensive valuation of UFPT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UFPT indicates a somewhat cheap valuation: UFPT is cheaper than 73.40% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of UFPT to the average of the S&P500 Index (22.13), we can say UFPT is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.52 | ||
| Fwd PE | 23.66 |
4.2 Price Multiples
75.53% of the companies in the same industry are more expensive than UFPT, based on the Enterprise Value to EBITDA ratio.
UFPT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. UFPT is cheaper than 80.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.44 | ||
| EV/EBITDA | 18.66 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates UFPT does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of UFPT may justify a higher PE ratio.
UFPT's earnings are expected to grow with 14.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.03
PEG (5Y)1.21
EPS Next 2Y13.82%
EPS Next 3Y14.28%
5. Dividend
5.1 Amount
No dividends for UFPT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
232.995
-4.28 (-1.8%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners110.86%
Inst Owner Change7.11%
Ins Owners3.69%
Ins Owner Change4.45%
Market Cap1.80B
Analysts78
Price Target317.22 (36.15%)
Short Float %13.72%
Short Ratio7.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.07%
Min EPS beat(2)3.81%
Max EPS beat(2)8.33%
EPS beat(4)4
Avg EPS beat(4)9.7%
Min EPS beat(4)3.81%
Max EPS beat(4)14.29%
EPS beat(8)7
Avg EPS beat(8)15.09%
EPS beat(12)11
Avg EPS beat(12)31.68%
EPS beat(16)14
Avg EPS beat(16)26.54%
Revenue beat(2)1
Avg Revenue beat(2)1.69%
Min Revenue beat(2)-0.3%
Max Revenue beat(2)3.67%
Revenue beat(4)3
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)7.43%
Revenue beat(8)6
Avg Revenue beat(8)2.62%
Revenue beat(12)10
Avg Revenue beat(12)5.5%
Revenue beat(16)14
Avg Revenue beat(16)5.64%
PT rev (1m)-18.37%
PT rev (3m)-18.37%
EPS NQ rev (1m)-1.06%
EPS NQ rev (3m)2.18%
EPS NY rev (1m)-3.31%
EPS NY rev (3m)-0.47%
Revenue NQ rev (1m)4.45%
Revenue NQ rev (3m)5.06%
Revenue NY rev (1m)0.41%
Revenue NY rev (3m)2.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.52 | ||
| Fwd PE | 23.66 | ||
| P/S | 3.28 | ||
| P/FCF | 30.44 | ||
| P/OCF | 25.76 | ||
| P/B | 4.98 | ||
| P/tB | 65.45 | ||
| EV/EBITDA | 18.66 |
EPS(TTM)8.17
EY3.51%
EPS(NY)9.85
Fwd EY4.23%
FCF(TTM)7.65
FCFY3.28%
OCF(TTM)9.05
OCFY3.88%
SpS71.02
BVpS46.78
TBVpS3.56
PEG (NY)2.03
PEG (5Y)1.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.88% | ||
| ROE | 17.6% | ||
| ROCE | 16.13% | ||
| ROIC | 13.23% | ||
| ROICexc | 13.57% | ||
| ROICexgc | 34.55% | ||
| OM | 16.57% | ||
| PM (TTM) | 11.59% | ||
| GM | 28.99% | ||
| FCFM | 10.78% |
ROA(3y)10.52%
ROA(5y)8.58%
ROE(3y)16.84%
ROE(5y)13.25%
ROIC(3y)11.64%
ROIC(5y)9.67%
ROICexc(3y)11.86%
ROICexc(5y)10.07%
ROICexgc(3y)27.75%
ROICexgc(5y)22.85%
ROCE(3y)14.19%
ROCE(5y)11.78%
ROICexcg growth 3Y28.55%
ROICexcg growth 5Y9.48%
ROICexc growth 3Y27.39%
ROICexc growth 5Y1.08%
OM growth 3Y16.51%
OM growth 5Y5.87%
PM growth 3Y14.91%
PM growth 5Y3.22%
GM growth 3Y5.49%
GM growth 5Y1.33%
F-Score4
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 3.1 | ||
| Debt/EBITDA | 1.59 | ||
| Cap/Depr | 65.69% | ||
| Cap/Sales | 1.96% | ||
| Interest Coverage | 9.01 | ||
| Cash Conversion | 65.12% | ||
| Profit Quality | 92.97% | ||
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.45 | ||
| Altman-Z | 6.15 |
F-Score4
WACC8.86%
ROIC/WACC1.49
Cap/Depr(3y)91.16%
Cap/Depr(5y)78.11%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.7%
Profit Quality(3y)58.22%
Profit Quality(5y)76.97%
High Growth Momentum
Growth
EPS 1Y (TTM)31.35%
EPS 3Y53.29%
EPS 5Y23.55%
EPS Q2Q%34.76%
EPS Next Y14.03%
EPS Next 2Y13.82%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue 1Y (TTM)34.43%
Revenue growth 3Y34.72%
Revenue growth 5Y20.52%
Sales Q2Q%41.08%
Revenue Next Year20.35%
Revenue Next 2Y12.73%
Revenue Next 3Y9.93%
Revenue Next 5YN/A
EBIT growth 1Y49.25%
EBIT growth 3Y56.96%
EBIT growth 5Y27.59%
EBIT Next Year48.19%
EBIT Next 3Y23.44%
EBIT Next 5YN/A
FCF growth 1Y552.02%
FCF growth 3Y85.71%
FCF growth 5Y17.47%
OCF growth 1Y207.54%
OCF growth 3Y67.03%
OCF growth 5Y16.35%